title: Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.
authors: Department of Cardiology, Oslo University Hospital Ulleval and University of Oslo, Oslo, Norway.
authors: Sigrun
authors: S
authors: Halvorsen
authors: Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
authors: Robert F
authors: RF
authors: Storey
authors: Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
authors: Bianca
authors: B
authors: Rocca
authors: Medizinische Klinik und Poliklinik I, Ludwig-Maximilians-Universität, Munich, Germany and DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
authors: Dirk
authors: D
authors: Sibbing
authors: Department of Cardiology, St Antonius Hospital, Nieuwegein, Netherlands.
authors: Jurrien
authors: J
authors: Ten Berg
authors: Department of Cardiology, Aarhus University Hospital, and Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
authors: Erik Lerkevang
authors: EL
authors: Grove
authors: 3rd Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminen Hospital, Montleartstrasse 37, Vienna, A-1160, Austria.
authors: Thomas W
authors: TW
authors: Weiss
authors: Univ Paris 06 (UPMC), ACTION Study Group, INSERM UMR_S 1166, ICAN, Institut de Cardiologie, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
authors: Jean-Philippe
authors: JP
authors: Collet
authors: Institute of Cardiology, Catholic University Medical School, Rome, Italy.
authors: Felicita
authors: F
authors: Andreotti
authors: Clinic for Internal Medicine and Pneumology, Katholisches Klinikum Oberhausen GmbH, St. Marien Hospital, Oberhausen, Germany.
authors: Dietrich C
authors: DC
authors: Gulba
authors: University of Birmingham Institute of Cardiovascular Sciences, City Hospital, United Kingdom; and Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark.
authors: Gregory Y H
authors: GYH
authors: Lip
authors: Medical Department, Region Hospital West, Herning/Holstebro.
authors: Steen
authors: S
authors: Husted
authors: Cardiovascular Research Center, CSIC-ICCC, HSCSP-Barcelona, Spain.
authors: Gemma
authors: G
authors: Vilahur
authors: Department of Cardiology, Leiria Hospital Centre, Portugal.
authors: Joao
authors: J
authors: Morais
authors: Emeritus Professor of Cardiology, P.C. Hooftstraat 188, CH Amsterdam, 1071, Netherlands.
authors: Freek W A
authors: FWA
authors: Verheugt
authors: Service of Digestive Diseases. University Hospital. University of Zaragoza. CIBERehd. IIS Aragón. Zaragoza, Spain.
authors: Angel
authors: A
authors: Lanas
authors: Centre for Clinical Brain Sciences, University of Edinburgh, UK.
authors: Rustam
authors: R
authors: Al-Shahi Salman
authors: Université Paris-Diderot, Sorbonne Paris Cité, DHU FIRE, AP-HP and INSERM U-1148, all in Paris, France. NHLI, Imperial College, Royal Brompton Hospital, London, UK.
authors: Philippe Gabriel
authors: PG
authors: Steg
authors: 3rd Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminen Hospital, Montleartstrasse 37, Vienna, A-1160, Austria.
authors: Kurt
authors: K
authors: Huber
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D032921:Consensus; D003324:Coronary Artery Disease / Q000188:drug therapy*; D057915:Drug Substitution; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D011183:Postoperative Complications / Q000209:etiology; D012307:Risk Factors; D015607:Stents; D013927:Thrombosis / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K